期刊文献+

常见中草药提取物及主要成分对细胞色素P4502C9抑制的研究进展 被引量:2

Research progress in the investigation of inhibitory effect of common Chinese herbal extracts and major components on Cytochrome P4502C9
下载PDF
导出
摘要 近年来中草药常与西药联合使用,用于疾病的预防和治疗。中草药成分复杂,可能影响药物代谢酶活性,存在引发中草药-药物相互作用(HDI)的潜在风险。目前HDI尚未受到足够重视。I相药物代谢酶细胞色素P4502C9(CYP2C9)与超过15%的药物代谢相关,尤其是其底物包括几种治疗窗较窄的临床常用药物。关注中草药对该酶活性的影响,对HDI的评估至关重要。本文综述了包括银杏、人参、丹参、生姜和大蒜等在内的常见中草药的提取物及其主要活性成分对CYP2C9的抑制作用,旨在为临床中草药与西药的合理使用提供理论依据。 Chinese herbs and Western medicine are frequently applied in combination for disease treatment and prevention currently.The complicated components of Chinese Herbs may affect the activity of drug metabolism enzymes,and thus lead to herb-drug interaction(HDI).However,HDI has been neglected.Cytochrome P4502C9(CYP2C9),a phase I drug metabolism enzyme,is responsible for the metabolism of more than 15%drugs,including several narrow therapeutic window drugs.Evaluation of the CYP2C9 activity alteration is essential for HDI prediction.The current article reviewed the inhibitory effect on CYP2C9 of the common Chinese herbal extracts and major components,such as Ginkgo Biloba,Ginseng,Danshen,Ginger and Garlic.The aim is to provide theoretical basis for rational use of Chinese herbs and Western medicine in clinic.
作者 陈悦悦 刘勇 李冬冬 黄豪 曹耘铭 丁倩 李巍 CHEN Yue-yue;LIU Yong;LI Dong-dong;HUANG Hao;CAO Yun-ming;DING Qian;LI Wei(Translational Medicine Research Institute,College of Medicine,Yangzhou University,Jiangsu Province,Yangzhou 225009,China;School of Life and Pharmaceutical Sciences,Dalian University of Technology,Liaoning Province,Dalian1 24221,China;Department of Pharmacy,Jiangdu People′s Hospital Affiliated to Yangzhou University,Jiangsu Province,Yangzhou 225214,China)
出处 《中国当代医药》 CAS 2021年第16期25-31,共7页 China Modern Medicine
基金 国家重点研发计划课题(2017YFC1702006) 江苏省扬州市科技计划项目(市级计划——社会发展项目)(YZ2020084) 扬州大学大学生科创基金项目(X20190747、X20190746、X20200754)。
关键词 细胞色素P4502C9 中草药 药物代谢 中药药物相互作用 Cytochrome P4502C9 Chinese herbs Drug metabolism Herb-drug interaction
  • 相关文献

参考文献2

二级参考文献35

  • 1Kawai T, Kinoshita K, Koyama K, Takahashi K. Anti-emetic principles of Magnolia obovata bark and Zingiber officinale rhizome. Planta Med 1994; 60:17-20.
  • 2Chrubasik S, Pittler MH, Roufogalis BD. Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles. Phytomedicine 2005; 12: 684-701.
  • 3Grant KL, Lutz RB. Alternative therapies: ginger. Am J Health Syst Pharm 2000; 57: 945-7.
  • 4Wei W, Chang YL, Xiao DW, Ping L, Lian WQ. Simultaneous determination of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol in rat plasma by liquid chromatography-mass spectrometry: Application to pharmacokinetics. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 671-9.
  • 5Govindarajan VS. Ginger — chemistry, technology, and qualityevaluation: part 1. Crit Rev Food Sci Nutr 1982; 17:1-96.
  • 6Young HY, Luo YL, Cheng HY, Hsieh WC, Liao JC, Peng WH. Analgesic and anti-inflammatory activities of [6]-gingerol. J Ethnopharmacol 2005; 96: 207-10.
  • 7Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull (Tokyo) 1992; 40: 387-91.
  • 8Shoji N, Iwasa A, Takemoto T, Ishida Y, Ohizumi Y. Cardiotonic principles of ginger (Zingiber officinale Roscoe). J Pharm Sci 1982; 71: 1174-5.
  • 9Ueki S, Miyoshi M, Shido 0, Hasegawa J, Watanabe T. Systemic administration of [6]-gingerol, a pungent constituent of ginger, induces hypothermia in rats via an inhibitory effect on metabolic rate. Eur J Pharmacol 2008; 584: 87-92.
  • 10Park KK, Chun KS, Lee JM, Lee SS, Surh YJ. Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett 1998; 129:139-44.

共引文献8

同被引文献34

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部